ARMP — Armata Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $96.34m
- $165.12m
- $4.53m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.03 | 9.65 | 10.3 | 14.9 | 13.5 |
Net Total Receivables | — | — | — | — | 3.36 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.66 | 10.8 | 15 | 27 | 19.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.21 | 12.8 | 38.1 | 46.7 | 57.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 25.5 | 39.5 | 69.8 | 95.8 | 98.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.88 | 6.71 | 4.81 | 24.9 | 16.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 10.9 | 20.7 | 44.4 | 59.8 | 130 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 14.6 | 18.9 | 25.4 | 36.1 | -32.1 |
Total Liabilities & Shareholders' Equity | 25.5 | 39.5 | 69.8 | 95.8 | 98.4 |
Total Common Shares Outstanding |